Change - Announcement of Cessation::Change - Announcement of Cessation

Issuer & Securities

Issuer/ Manager
TIANJIN ZHONG XIN PHARM GROUP
Securities
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
17-May-2021 18:40:36
Status
New
Announcement Sub Title
Change - Announcement of Cessation
Announcement Reference
SG210517OTHROARX
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board
Description (Please provide a detailed description of the event in the box below)
Announcement of Cessation of Independent Director

Additional Details

Name Of Person
Qiang Zhiyuan
Age
65
Is effective date of cessation known?
Yes
If yes, please provide the date
17/05/2021
Detailed Reason (s) for cessation
Term of office has expired.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
15/05/2015
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Lead Independent, Non-Executive Director, Chairman of Audit Committee and a member of the Strategy Committee.
Role and responsibilities
Duties as Lead Independent, Non-Executive Director, Chairman of Audit Committee and a member of the Strategy Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
NIL
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
NIL
Present
NIL